| John William Schulhoff, MD | |
|
1200 Brooks Ln Ste 220, Clairton, PA 15025-3761 | |
| (412) 469-1002 | |
| (412) 469-8925 |
| Full Name | John William Schulhoff |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 53 Years |
| Location | 1200 Brooks Ln Ste 220, Clairton, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184773137 | NPI | - | NPPES |
| 10935840 | Other | CAQH | |
| 000671097 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | MD015041E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson Hospital | Jefferson hills, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Pittsburgh Urology Associates | 8123248127 | 3 |
News Archive
Though most of the state-run online insurance marketplaces have not been hobbled by the same types of difficulties that marred the federal exchange's launch, some states are successfully enrolling their residents while others still confront hurdles.
A recent paper available on the preprint server bioRxiv* reports preliminary data on the ability of low molecular weight heparins to interact with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), elicit structural changes in its key proteins and subsequently halt cell invasion.
Scientists have developed a new technique for looking at the initial steps of DNA oxidation – a process which can lead to DNA damage, mutations and cancers. The breakthrough, which uses DNA in crystals, should help related research in the fields of cancer medicine and drug development.
New technologies for the diagnosis of cancer are rapidly changing the clinical practice of oncology. As scientists learn more about the molecular basis of cancer, the development of new tools capable of multiple, inexpensive biomarker measurements on small samples of clinical tissue will become essential to the success of genetically informed and personalized cancer therapies.
› Verified 9 days ago
| Entity Name | South Pittsburgh Urology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013328038 PECOS PAC ID: 8123248127 Enrollment ID: O20140925000278 |
News Archive
Though most of the state-run online insurance marketplaces have not been hobbled by the same types of difficulties that marred the federal exchange's launch, some states are successfully enrolling their residents while others still confront hurdles.
A recent paper available on the preprint server bioRxiv* reports preliminary data on the ability of low molecular weight heparins to interact with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), elicit structural changes in its key proteins and subsequently halt cell invasion.
Scientists have developed a new technique for looking at the initial steps of DNA oxidation – a process which can lead to DNA damage, mutations and cancers. The breakthrough, which uses DNA in crystals, should help related research in the fields of cancer medicine and drug development.
New technologies for the diagnosis of cancer are rapidly changing the clinical practice of oncology. As scientists learn more about the molecular basis of cancer, the development of new tools capable of multiple, inexpensive biomarker measurements on small samples of clinical tissue will become essential to the success of genetically informed and personalized cancer therapies.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John William Schulhoff, MD 1200 Brooks Ln Ste 220, Clairton, PA 15025-3761 Ph: (412) 469-1002 | John William Schulhoff, MD 1200 Brooks Ln Ste 220, Clairton, PA 15025-3761 Ph: (412) 469-1002 |
News Archive
Though most of the state-run online insurance marketplaces have not been hobbled by the same types of difficulties that marred the federal exchange's launch, some states are successfully enrolling their residents while others still confront hurdles.
A recent paper available on the preprint server bioRxiv* reports preliminary data on the ability of low molecular weight heparins to interact with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), elicit structural changes in its key proteins and subsequently halt cell invasion.
Scientists have developed a new technique for looking at the initial steps of DNA oxidation – a process which can lead to DNA damage, mutations and cancers. The breakthrough, which uses DNA in crystals, should help related research in the fields of cancer medicine and drug development.
New technologies for the diagnosis of cancer are rapidly changing the clinical practice of oncology. As scientists learn more about the molecular basis of cancer, the development of new tools capable of multiple, inexpensive biomarker measurements on small samples of clinical tissue will become essential to the success of genetically informed and personalized cancer therapies.
› Verified 9 days ago
Vijay Satappa Athani, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1200 Brooks Ln, Suite 220, Clairton, PA 15025 Phone: 412-469-1002 Fax: 412-469-8925 | |
James Edgar Allen, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1200 Brooks Ln, Suite 220, Clairton, PA 15025 Phone: 412-469-1002 Fax: 412-469-8925 |